The global virus filtration market is witnessing rapid growth as demand for advanced filtration technologies surges across biopharmaceuticals, healthcare, and environmental applications. Valued at USD 5,057 million in 2024, the market is projected to reach USD 21,237 million by 2035, expanding at an impressive CAGR of 13.9% during the forecast period of 2025 to 2035.
Over the next decade, the industry is expected to grow 3.6 times, creating an incremental dollar opportunity of USD 15,458 million. This growth trajectory highlights the market's immense potential, driven by rising safety regulations, the expansion of biologics, and the increasing need for contamination-free medical devices and pharmaceuticals.
Market Overview:
Virus filtration plays a crucial role in removing potential viral contaminants from products such as vaccines, therapeutic proteins, blood plasma derivatives, and medical devices. With the rise of biological therapies and gene-based treatments, regulatory bodies worldwide have tightened safety standards, thereby creating a strong demand for advanced virus filtration technologies.
The market is also supported by growing investments in healthcare infrastructure, increasing adoption of single-use systems in bioprocessing, and heightened awareness regarding water and air purification. The COVID-19 pandemic accelerated the adoption of virus filtration technologies, and this momentum continues as pharmaceutical and biotechnology companies prioritize robust contamination control measures.
Full Market Report Available for Delivery. For Purchase or Customization, Please Request Here: https://www.factmr.com/connectus/sample?flag=S&rep_id=7611
Comments
0 comment